Inhibitors of the Arachidonic Acid Cascade: Interfering with Multiple Pathways
Citations Over TimeTop 10% of 2013 papers
Abstract
Modulators of the arachidonic acid cascade have been in the focus of research for treatments of inflammation and pain for several decades. Targeting this complex pathway experiences a paradigm change towards the design and development of multi-target inhibitors, exhibiting improved efficacy and less undesired side effects. This minireview summarizes recent developments in the field of designed multi-target ligands of the arachidonic acid cascade. In addition to the well-known dual inhibitors of 5-lipoxygenase and cyclooxygenase-2 such as licofelone, very recent developments are discussed. Especially, multi-target inhibitors interfering with the cytochrome P450 pathway via inhibition of soluble epoxide hydrolase seem to offer a novel opportunity for development of novel anti-inflammatory drugs.
Related Papers
- → Convergent Oxygenation of Arachidonic Acid by 5-Lipoxygenase and Cyclooxygenase-2(2005)36 cited
- → Human alveolar macrophage arachidonic acid metabolism(1988)200 cited
- → Role of COX-2 in the Enhanced Vasoconstrictor Effect of Arachidonic Acid in the Diabetic Rat Kidney(2003)53 cited
- → Inhibition of COX activity by NSAIDs or ascorbate increases cAMP levels and enhances differentiation in 1α,25-dihydroxyvitamin D3-induced HL-60 cells(2005)17 cited
- Progress on the Treatment for Hypertension of Epoxide Hydrolase and Its Mechanisms(2008)